Delivery Order SPE2DB22D1202-SPE2DB24FVEP9

Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,558.34 firm fixed-price delivery order is for the supply of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a pharmaceutical product. This award is not associated with any set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,861.78 firm fixed-price delivery order is for the supply of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a pharmaceutical product. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,625.19 firm fixed price delivery order is for the supply of 60 tablets of the prescription medication BRIVIACT 100 MG. The contract has an ultimate completion date of June 11, 2025 and is not set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $7,547.98 for the supply of BRIVIACT 10 MG/ML ORAL SOLN 300ML. The contract is placed by the Defense Logistics Agency (DLA), a defense agency, and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,705.58 firm fixed price delivery order is for the supply of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a pharmaceutical product. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This...
This federal contract award is for the pharmaceutical product BRIVIACT 10 MG/ML ORAL SOLN 300ML, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The $1,861.78 firm fixed price delivery order has a period of performance through March 5, 2025. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, to...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,594.79 Firm Fixed Price Delivery Order is for the supply of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a prescription medication. The contract has an ultimate completion date of October 9, 2024 and does not have a set-aside designation. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,990.00 firm fixed-price delivery order is for the supply of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a prescription medication. The contract has an ultimate completion date of November 27, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Amerisourcebergen Corporation) is for the delivery of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,336.00 firm fixed price contract is a delivery order issued under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for a wide range of pharmaceutical products and medical supplies to support the Department of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,237.50 firm fixed-price delivery order is for the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of April 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVEP9
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,864.56 firm fixed-price delivery order is for the supply of 300 milliliters of the pharmaceutical product BRIVIACT 10 MG/ML ORAL SOLN. Amerisourcebergen, a large pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 9/23/24, 10:14 AM